CytoDyn Inc.·4

Sep 22, 8:21 PM ET

Migliarese Antonio 4

4 · CytoDyn Inc. · Filed Sep 22, 2022

Insider Transaction Report

Form 4
Period: 2022-09-20
Migliarese Antonio
Chief Financial Officer
Transactions
  • Award

    Non-qualified stock option (right to buy)

    2022-09-20+630,222630,222 total
    Exercise: $0.58Exp: 2032-09-20Common Stock (630,222 underlying)
Footnotes (1)
  • [F1]25% of the award will vest on January 24, 2023; thereafter, the balance will vest in 36 equal monthly installments, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date.

Documents

1 file
  • 4
    tm2226067-5_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT